170 related articles for article (PubMed ID: 3030073)
1. Nigral and adrenal grafts in parkinsonism: recent basic and clinical studies.
Olson L; Backlund EO; Gerhardt G; Hoffer B; Lindvall O; Rose G; Seiger A; Strömberg I
Adv Neurol; 1987; 45():85-94. PubMed ID: 3030073
[No Abstract] [Full Text] [Related]
2. Pathogenesis and animal studies of Parkinson's disease.
Oertel WH; Kupsch A
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901
[TBL] [Abstract][Full Text] [Related]
3. Thirty years of dopamine research.
Carlsson A
Adv Neurol; 1993; 60():1-10. PubMed ID: 8093570
[No Abstract] [Full Text] [Related]
4. Tissue implants in treatment of parkinsonian syndromes in animals and implications for use of tissue implants in humans.
Kopin IJ; Bankiewicz KS; Plunkett RJ; Jacobowitz DM; Oldfield EH
Adv Neurol; 1993; 60():707-14. PubMed ID: 8420215
[No Abstract] [Full Text] [Related]
5. Pathogenesis of Parkinson's disease.
Riederer P; Lange KW
Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):295-300. PubMed ID: 1623255
[TBL] [Abstract][Full Text] [Related]
6. Transplantation advances in Parkinson's disease.
Sladek JR; Redmond DE; Collier TJ; Elsworth JD; Roth RH
Mov Disord; 1989; 4 Suppl 1():S120-5. PubMed ID: 2786143
[No Abstract] [Full Text] [Related]
7. Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology.
Imai H; Nakamura T; Endo K; Narabayashi H
Brain Res; 1988 Dec; 474(2):327-32. PubMed ID: 3264746
[TBL] [Abstract][Full Text] [Related]
8. The neuronal mechanism underlying parkinsonism and dyskinesia, and differential roles of the putamen and caudate nucleus.
Yoshida M
Adv Neurol; 1993; 60():71-7. PubMed ID: 8380531
[TBL] [Abstract][Full Text] [Related]
9. Saccade responses to dopamine in human MPTP-induced parkinsonism.
Hotson JR; Langston EB; Langston JW
Ann Neurol; 1986 Oct; 20(4):456-63. PubMed ID: 3491578
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of monoamine-producing cell systems in oculo and intracranially: experiments in search of a treatment for Parkinson's Disease.
Olson L; Backlund EO; Freed W; Herrera-Marschitz M; Hoffer B; Seiger A; Strömberg I
Ann N Y Acad Sci; 1985; 457():105-26. PubMed ID: 3913358
[No Abstract] [Full Text] [Related]
11. Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.
Graybiel AM; Moratalla R; Quinn B; DeLanney LE; Irwin I; Langston JW
Adv Neurol; 1993; 60():34-9. PubMed ID: 8420148
[No Abstract] [Full Text] [Related]
12. Transplantation and surgical treatment of parkinsonian syndromes.
Widner H; Rehncrona S
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):344-9. PubMed ID: 8507904
[TBL] [Abstract][Full Text] [Related]
13. Dopamine in the extrapyramidal motor function. A study based upon the MPTP-induced primate model of parkinsonism.
Chiueh CC
Ann N Y Acad Sci; 1988; 515():226-38. PubMed ID: 3259118
[No Abstract] [Full Text] [Related]
14. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Jenner P; Marsden CD
J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
[TBL] [Abstract][Full Text] [Related]
15. [Neurobiologic and pharmacologic studies on the pathogenesis of Parkinson disease].
Brücke T; Riederer P
Wien Med Wochenschr; 1986 Aug; 136(15-16):401-8. PubMed ID: 2878540
[TBL] [Abstract][Full Text] [Related]
16. Transferrin receptor regulation in Parkinson's disease and MPTP-treated mice.
Mash DC; Sanchez-Ramos J; Weiner WJ
Adv Neurol; 1993; 60():133-9. PubMed ID: 8420130
[No Abstract] [Full Text] [Related]
17. The visual system in Parkinson's disease.
Bodis-Wollner I; Tagliati M
Adv Neurol; 1993; 60():390-4. PubMed ID: 8420159
[No Abstract] [Full Text] [Related]
18. Recovery of dopaminergic fibers in striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse is enhanced by grafts of adrenal medulla.
Bohn MC; Marciano F; Cupit L; Gash DM
Prog Brain Res; 1988; 78():535-42. PubMed ID: 3266803
[No Abstract] [Full Text] [Related]
19. The MPTP model of Parkinson's disease.
Smeyne RJ; Jackson-Lewis V
Brain Res Mol Brain Res; 2005 Mar; 134(1):57-66. PubMed ID: 15790530
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
